Clincosm LogoSign in Get a demo

Non-Hodgkin Lymphoma

Showing NaN - NaN of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

Non-Hodgkin Lymphoma Trial in Worldwide (Tisagenlecleucel after optional bridging and lymphodepleting chemo, Platinum-based

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
  • Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)
  • La Jolla, California
  • +66 more
Jan 6, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

Recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Duarte, California
  • +23 more
Dec 28, 2022

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

B-Lymphoid Malignancies, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Fludarabine,

Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 1, 2022

Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Non-Hodgkin Lymphoma
    • Miami, Florida
    • +7 more
    Jun 23, 2022

    Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-Hodgkin Lymphoma
    • B-cell Acute Lymphoblastic Leukemia
    • PBCAR0191
    • +2 more
    • Duarte, California
    • +9 more
    Apr 18, 2022

    Collecting and Storing Tissue Samples From Rare or Cutaneous

    Active, not recruiting
    • Adult Immunoblastic Lymphoma
    • +12 more
    • Cytology Specimen Collection Procedure
    • Birmingham, Alabama
    • +129 more
    Mar 23, 2022

    Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Goodyear, Arizona
    • +16 more
    Mar 18, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

    Completed
    • Hodgkin Lymphoma
    • Non-hodgkin Lymphoma
    • AB-205
    • Duarte, California
    • +8 more
    Mar 1, 2022

    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

    Completed
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Tucson, Arizona
    • +9 more
    Feb 10, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +12 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
    • +2 more
    Feb 17, 2022

    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • autologous or syngeneic PBTLs and EBV-CTLs
    • Houston, Texas
    • +1 more
    Feb 6, 2022

    Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

    Recruiting
    • Breast Cancer
    • +7 more
    • Santa Monica, California
    • +19 more
    Jan 6, 2022

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,

    Completed
    Has Results
    • Anaplastic Large-Cell Lymphoma
    • +2 more
    • brentuximab vedotin
    • +4 more
    • Gilbert, Arizona
    • +143 more
    Nov 1, 2021

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United Kingdom, United States (Camidanlumab tesirine)

    Completed
    Has Results
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Camidanlumab tesirine
    • Duarte, California
    • +11 more
    Jul 12, 2021

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

    Completed
    Has Results
    • Acute Lymphoblastic Leukemia
    • +5 more
    • Tetanus
    • Houston, Texas
    • +1 more
    Apr 20, 2020

    Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Lymphoproliferative Disorder Trial in Houston (LMP specific T cells)

    Completed
    • Hodgkin Lymphoma
    • +5 more
    • LMP specific T cells
    • Houston, Texas
    • +1 more
    Feb 5, 2020